MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

Strona główna・Stock List・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Closed

SectorHealthcare

26.49 -2.29

Buy Sell

Overview

Share price change

24h

Current

Min

26.1

Max

26.8

Key metrics
By Trading Economics
Income	-5.8M 40M
Sales	16M 200M
P/E Sector Avg	8.577 37.257
EPS	0.92
Profit margin	19.839
Employees	268
EBITDA	3M 59M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+65.85% upside

Dividends
By Dow Jones
Next Earnings	28 paź 2025

Market Stats
By TradingEconomics
Market Cap	-511M 1.5B
Previous open	28.78
Previous close	26.49

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

29.8 / N/A Support & Resistance

Harmony Biosciences Holdings Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

8 paź 2025, 20:45 UTC

Earnings

Costco Wholesale Sales Climb in September, Early October

8 paź 2025, 20:12 UTC

Major Market Movers

Acquisitions, Mergers, Takeovers

TaskUs Shares Fall After Holders Reject Take-Private Deal

8 paź 2025, 16:39 UTC

Major Market Movers

Mining Shares Rise as Gold Prices Soar

8 paź 2025, 23:45 UTC

Market Talk

Nikkei May Rise on Weaker Yen -- Market Talk

8 paź 2025, 23:43 UTC

Market Talk

Gold Falls on Possible Profit-Taking -- Market Talk

8 paź 2025, 23:18 UTC

Acquisitions, Mergers, Takeovers

JD Logistics to Finance Acquisition Using Internal Funds

8 paź 2025, 23:17 UTC

Acquisitions, Mergers, Takeovers

JD Logistics to Buy On-Demand Delivery Services Business for US$270.0M

8 paź 2025, 23:16 UTC

Acquisitions, Mergers, Takeovers

JD Logistics to Buy JD.com's On-Demand Delivery Services Business Dajiang and Dasheng

8 paź 2025, 21:54 UTC

Market Talk

Earnings

James Hardie Could Beat Annual Earnings Goal -- Market Talk

8 paź 2025, 21:30 UTC

Market Talk

Boab Metals Bull Delivers Second Upgrade in a Month -- Market Talk

8 paź 2025, 21:26 UTC

Market Talk

Earnings

Transurban's 1Q Traffic Growth Beats Hopes -- Market Talk

8 paź 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

8 paź 2025, 19:15 UTC

Market Talk

Geopolitical Risk Supports Gains in Oil Futures -- Market Talk

8 paź 2025, 19:01 UTC

Market Talk

U.S. Natural Gas Futures Pull Back Ahead of Storage Data -- Market Talk

8 paź 2025, 18:47 UTC

Market Talk

Coca-Cola North America Sales Buoy International Weakness -- Market Talk

8 paź 2025, 18:46 UTC

Acquisitions, Mergers, Takeovers

TaskUs: Neither Party Will Be Required to Pay Termination Fee as Result of Planned Mutual Decision to Terminate

8 paź 2025, 18:46 UTC

Acquisitions, Mergers, Takeovers

TaskUs Will Remain a Publicly Traded Co >TASK

8 paź 2025, 18:46 UTC

Acquisitions, Mergers, Takeovers

TaskUs Does Not Plan to Convene Another Special Meeting of Stockholders >TASK

8 paź 2025, 18:45 UTC

Acquisitions, Mergers, Takeovers

TaskUs Didn't Receive Votes Necessary to Approve Transaction Agreement With Affil of Blackstone >TASK

8 paź 2025, 18:07 UTC

Market Talk

Mexico's Inflation Seen Edging Up in September -- Market Talk

8 paź 2025, 16:20 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Energy & Utilities Roundup: Market Talk

8 paź 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

8 paź 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

8 paź 2025, 15:57 UTC

Market Talk

Oil Rises Despite U.S. Crude Stockpiles Build -- Market Talk

8 paź 2025, 15:56 UTC

Market Talk

Teck Resources' Chile Mine Issues Appear Transitory -- Market Talk

8 paź 2025, 15:53 UTC

Market Talk

Argentine Sovereign Debt Seen as Attractive -- Market Talk

8 paź 2025, 15:44 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical: Broadwood's Proposal to Vote Down Merger Could Allow It to Take Control Without Paying Any Premium

8 paź 2025, 15:44 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical Board and Management Disagree With Recommendation Issued by Glass Lewis >STAA

8 paź 2025, 15:43 UTC

Acquisitions, Mergers, Takeovers

STAAR Surgical Board Reiterates Unanimous Recommendation Holders Vote for Alcon Merger

8 paź 2025, 15:42 UTC

Acquisitions, Mergers, Takeovers

Oracle Is a Buy-the-Dip Opportunity, Analyst Says. How the Stock Could Rise 23%. -- Barrons.com

Peer Comparison

Price change

Harmony Biosciences Holdings Inc Forecast

Price Target

By TipRanks

65.85% upside

12 Months Forecast

Average 44.1 USD 65.85%

High 62 USD

Low 31 USD

Based on 11 Wall Street analysts offering 12 month price targets forHarmony Biosciences Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

11 ratings

Buy

Hold

Sell

Based on 11 analysts giving stock ratings to Harmony Biosciences Holdings Inc - Dist in the past 3 months.

Technical Score

By Trading Central

29.8 / N/ASupport & Resistance

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.